Jacksim personal page - To The Moon

Jacksim

Jacksim

No personal profile

339Follow

5Followers

0Topic

0Badge

2022-04-12

[Call] [Call] [Call]

@mantaru:$Visa(V)$the great red

2022-03-18

[Call]

Pfizer Shares Rose More Than 2% in Morning Trading

2022-03-06

Great ariticle, would you like to share it?

US IPO Week Ahead: Market Slowdown Continues with No IPOs Scheduled

2022-01-08

[Surprised] [Surprised] [Surprised]

GameStop Price Alert: Are NFTs and Cryptos Enough to End Bear Market?

2022-01-05

[Miser] [Miser] [Miser]

Job Openings Reach 10.6 Million in November as Tight Labor Market Persists

2022-01-04

[Like] [Like] [Like]

Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%

2021-08-21

Good...

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4090666679009510","uuid":"4090666679009510","gmtCreate":1627565437053,"gmtModify":1629532127998,"name":"Jacksim","pinyin":"jacksim","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":339,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.10","exceedPercentage":"60.73%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9014475560,"gmtCreate":1649716591889,"gmtModify":1676534554292,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;","listText":"[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;","text":"[Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9014475560","repostId":"9014585114","repostType":1,"repost":{"id":9014585114,"gmtCreate":1649684354587,"gmtModify":1676534550460,"author":{"id":"3581582691031963","authorId":"3581582691031963","name":"mantaru","avatar":"https://static.tigerbbs.com/d383ec25018126b5add320ac3acf90aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581582691031963","idStr":"3581582691031963"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/V\">$Visa(V)$</a>the great red","listText":"<a href=\"https://ttm.financial/S/V\">$Visa(V)$</a>the great red","text":"$Visa(V)$the great red","images":[{"img":"https://community-static.tradeup.com/news/8cd9fbd56551df80544477624d2f037c","width":"1080","height":"3182"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9014585114","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9035140506,"gmtCreate":1647558026338,"gmtModify":1676534242901,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Call]&nbsp;","listText":"[Call]&nbsp;","text":"[Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035140506","repostId":"1165019745","repostType":4,"repost":{"id":"1165019745","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647530294,"share":"https://ttm.financial/m/news/1165019745?lang=en_US&edition=fundamental","pubTime":"2022-03-17 23:18","market":"us","language":"en","title":"Pfizer Shares Rose More Than 2% in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1165019745","media":"Tiger Newspress","summary":"Pfizer shares rose more than 2% in morning trading.Thirty five generic drugmakers around the world w","content":"<html><head></head><body><p>Pfizer shares rose more than 2% in morning trading.<img src=\"https://static.tigerbbs.com/4a03e4c180b16dbc8dee58435f81f61a\" tg-width=\"713\" tg-height=\"629\" referrerpolicy=\"no-referrer\"/>Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc&#39;s highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday.</p><p>Pfizer struck a deal last year with the group to allow generic drugmakers to make the pills for 95 low- and middle-income countries. They have been working since then to select the drugmakers they will license.</p><p>Paxlovid is expected to be an important tool in the fight against COVID-19 after it reduced hospitalizations in high-risk patients by around 90% in a clinical trial. The results were significantly better than those for Merck &amp; Co&#39;s rival antiviral pill molnupiravir in its clinical trial.</p><p>Pfizer won’t receive royalties from sales covered by the pact as long as Covid remains classified as an international public-health emergency by the World Health Organization, according to the patent pool.</p><p>After the pandemic, middle-income nations will be subject to a 5% royalty for sales to the public sector and 10% for sales to the private sector. There will be no royalty payment for low-income countries.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shares Rose More Than 2% in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shares Rose More Than 2% in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 23:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Pfizer shares rose more than 2% in morning trading.<img src=\"https://static.tigerbbs.com/4a03e4c180b16dbc8dee58435f81f61a\" tg-width=\"713\" tg-height=\"629\" referrerpolicy=\"no-referrer\"/>Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc&#39;s highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday.</p><p>Pfizer struck a deal last year with the group to allow generic drugmakers to make the pills for 95 low- and middle-income countries. They have been working since then to select the drugmakers they will license.</p><p>Paxlovid is expected to be an important tool in the fight against COVID-19 after it reduced hospitalizations in high-risk patients by around 90% in a clinical trial. The results were significantly better than those for Merck &amp; Co&#39;s rival antiviral pill molnupiravir in its clinical trial.</p><p>Pfizer won’t receive royalties from sales covered by the pact as long as Covid remains classified as an international public-health emergency by the World Health Organization, according to the patent pool.</p><p>After the pandemic, middle-income nations will be subject to a 5% royalty for sales to the public sector and 10% for sales to the private sector. There will be no royalty payment for low-income countries.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165019745","content_text":"Pfizer shares rose more than 2% in morning trading.Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc's highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday.Pfizer struck a deal last year with the group to allow generic drugmakers to make the pills for 95 low- and middle-income countries. They have been working since then to select the drugmakers they will license.Paxlovid is expected to be an important tool in the fight against COVID-19 after it reduced hospitalizations in high-risk patients by around 90% in a clinical trial. The results were significantly better than those for Merck & Co's rival antiviral pill molnupiravir in its clinical trial.Pfizer won’t receive royalties from sales covered by the pact as long as Covid remains classified as an international public-health emergency by the World Health Organization, according to the patent pool.After the pandemic, middle-income nations will be subject to a 5% royalty for sales to the public sector and 10% for sales to the private sector. There will be no royalty payment for low-income countries.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9031814765,"gmtCreate":1646519895270,"gmtModify":1676534135565,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031814765","repostId":"1123705020","repostType":4,"repost":{"id":"1123705020","kind":"news","pubTimestamp":1646439679,"share":"https://ttm.financial/m/news/1123705020?lang=en_US&edition=fundamental","pubTime":"2022-03-05 08:21","market":"us","language":"en","title":"US IPO Week Ahead: Market Slowdown Continues with No IPOs Scheduled","url":"https://stock-news.laohu8.com/highlight/detail?id=1123705020","media":"Renaissance Capital","summary":"No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar","content":"<html><head></head><body><p>No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar during the week.</p><p>The typical February lull was quieter than expected, with few large filings and no launches after Presidents’ Day in light of the repercussions of war in Europe. There are a number of large issuers waiting in the pipeline once the IPO market becomes more amenable, led by Bausch Health spin-off <b>Bausch + Lomb</b>(BLCO) and Greek yogurt brand <b>Chobani</b>(CHO), which aims to be the latest public benefit corp to go public.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Market Slowdown Continues with No IPOs Scheduled</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Market Slowdown Continues with No IPOs Scheduled\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-05 08:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91318/US-IPO-Week-Ahead-Market-slowdown-continues-with-no-IPOs-scheduled><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar during the week.The typical February lull was quieter than expected, with few large filings and no ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91318/US-IPO-Week-Ahead-Market-slowdown-continues-with-no-IPOs-scheduled\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91318/US-IPO-Week-Ahead-Market-slowdown-continues-with-no-IPOs-scheduled","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123705020","content_text":"No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar during the week.The typical February lull was quieter than expected, with few large filings and no launches after Presidents’ Day in light of the repercussions of war in Europe. There are a number of large issuers waiting in the pipeline once the IPO market becomes more amenable, led by Bausch Health spin-off Bausch + Lomb(BLCO) and Greek yogurt brand Chobani(CHO), which aims to be the latest public benefit corp to go public.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1978,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006309930,"gmtCreate":1641601562751,"gmtModify":1676533633018,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Surprised]&nbsp;[Surprised]&nbsp;[Surprised]&nbsp;","listText":"[Surprised]&nbsp;[Surprised]&nbsp;[Surprised]&nbsp;","text":"[Surprised] [Surprised] [Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006309930","repostId":"1120541362","repostType":4,"repost":{"id":"1120541362","kind":"news","pubTimestamp":1641598507,"share":"https://ttm.financial/m/news/1120541362?lang=en_US&edition=fundamental","pubTime":"2022-01-08 07:35","market":"us","language":"en","title":"GameStop Price Alert: Are NFTs and Cryptos Enough to End Bear Market?","url":"https://stock-news.laohu8.com/highlight/detail?id=1120541362","media":"TheStreet","summary":"GameStop stock has been under a ton of pressure lately. However, the market is selling the news on i","content":"<html><head></head><body><p>GameStop stock has been under a ton of pressure lately. However, the market is selling the news on its NFTs and crypto plan.</p><p>Forget the employment report. GameStop wanted the spotlight on Friday, which helped vault it higher by more than 20% at the open.</p><p>Driving the gains is the company’s new plan to leverage NFTs and cryptocurrencies. From an earlier piece on <i>TheStreet:</i></p><blockquote>&#34;It looks like GameStop&#39;s launch in crypto is going to start with trying to be a leading marketplace for gaming NFT&#39;s,&#34; Hedgeye Risk Management analyst Jeremy Mclean said in a note this week. &#34;GameStop is one of the first real Retail brand names in this NFT space. We think there is a real commercial opportunity to being there.&#34;</blockquote><p>While the stock soared on the news in pre-market trading, it was up even more in the after-hours on Thursday.</p><p>However, the stock has since faded from the open and is now up “just” 7.3%.</p><p>That’s not bad given the mixed picture in the overall market following the labor report, but it’s a blow to those who were long and had large gains at the open.</p><p>Worse, the fade came from an important area on the chart.</p><p><b>Trading GameStop Stock</b></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/024bc53e87a739a2f541f98b362554fb\" tg-width=\"1139\" tg-height=\"866\" referrerpolicy=\"no-referrer\"/><span>Daily chart of GameStop stock.</span></p><p>On Dec. 3, GameStop stock pulled back to $159.05 and bounced, but plunged back below that mark a few days later when the company reported disappointing earnings.</p><p>That level quickly turned into resistance, an observation that remained true on Friday morning.</p><p>I flagged the $159 level ahead of earnings, arguing that a break of it could put the $116 to $118 area in play.</p><p>The stock ended up bottoming about $3 above that range, at $121-and-change. So what do we do from here?</p><p>Following that painful but obvious rejection from this morning, GameStop isn’t done disappointing the bulls. Shares knifed right through the 10-day and 21-day moving averages as well.</p><p>It simply <i>has</i> to find its footing before bulls can trust it on the long side.</p><p>So far, the fourth-quarter low at $129.50 has been a decent area of stability. Even amid the one break lower that sent GameStop stock to the $121.14 low, the stock was still able to close over the fourth-quarter low by the end of the session.</p><p>On the plus side, it did fill today’s gap.</p><p>Over Thursday high at $137.70 and<i>aggressive</i>bulls can be long GameStop, targeting the 10-day and 21-day moving averages as the first target, then $159 as the second.</p><p>Above $160.50 and GameStop could make a run to its 50-day moving average.</p><p>Otherwise, below $137.70 and the fourth-quarter low is in play, while the 2022 low remains vulnerable.</p><p>Personally, I wouldn&#39;t consider GameStop a safe trade on the long side. Not after today&#39;s heavy fade.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop Price Alert: Are NFTs and Cryptos Enough to End Bear Market?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop Price Alert: Are NFTs and Cryptos Enough to End Bear Market?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 07:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-gamestop-gme-stock-nft-crypto-plans><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GameStop stock has been under a ton of pressure lately. However, the market is selling the news on its NFTs and crypto plan.Forget the employment report. GameStop wanted the spotlight on Friday, which...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-gamestop-gme-stock-nft-crypto-plans\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://www.thestreet.com/investing/trading-gamestop-gme-stock-nft-crypto-plans","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120541362","content_text":"GameStop stock has been under a ton of pressure lately. However, the market is selling the news on its NFTs and crypto plan.Forget the employment report. GameStop wanted the spotlight on Friday, which helped vault it higher by more than 20% at the open.Driving the gains is the company’s new plan to leverage NFTs and cryptocurrencies. From an earlier piece on TheStreet:\"It looks like GameStop's launch in crypto is going to start with trying to be a leading marketplace for gaming NFT's,\" Hedgeye Risk Management analyst Jeremy Mclean said in a note this week. \"GameStop is one of the first real Retail brand names in this NFT space. We think there is a real commercial opportunity to being there.\"While the stock soared on the news in pre-market trading, it was up even more in the after-hours on Thursday.However, the stock has since faded from the open and is now up “just” 7.3%.That’s not bad given the mixed picture in the overall market following the labor report, but it’s a blow to those who were long and had large gains at the open.Worse, the fade came from an important area on the chart.Trading GameStop StockDaily chart of GameStop stock.On Dec. 3, GameStop stock pulled back to $159.05 and bounced, but plunged back below that mark a few days later when the company reported disappointing earnings.That level quickly turned into resistance, an observation that remained true on Friday morning.I flagged the $159 level ahead of earnings, arguing that a break of it could put the $116 to $118 area in play.The stock ended up bottoming about $3 above that range, at $121-and-change. So what do we do from here?Following that painful but obvious rejection from this morning, GameStop isn’t done disappointing the bulls. Shares knifed right through the 10-day and 21-day moving averages as well.It simply has to find its footing before bulls can trust it on the long side.So far, the fourth-quarter low at $129.50 has been a decent area of stability. Even amid the one break lower that sent GameStop stock to the $121.14 low, the stock was still able to close over the fourth-quarter low by the end of the session.On the plus side, it did fill today’s gap.Over Thursday high at $137.70 andaggressivebulls can be long GameStop, targeting the 10-day and 21-day moving averages as the first target, then $159 as the second.Above $160.50 and GameStop could make a run to its 50-day moving average.Otherwise, below $137.70 and the fourth-quarter low is in play, while the 2022 low remains vulnerable.Personally, I wouldn't consider GameStop a safe trade on the long side. Not after today's heavy fade.","news_type":1,"symbols_score_info":{"GME":0.9}},"isVote":1,"tweetType":1,"viewCount":2662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001785573,"gmtCreate":1641332984240,"gmtModify":1676533597638,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;","listText":"[Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;","text":"[Miser] [Miser] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001785573","repostId":"1108070113","repostType":4,"repost":{"id":"1108070113","kind":"news","pubTimestamp":1641308842,"share":"https://ttm.financial/m/news/1108070113?lang=en_US&edition=fundamental","pubTime":"2022-01-04 23:07","market":"us","language":"en","title":"Job Openings Reach 10.6 Million in November as Tight Labor Market Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=1108070113","media":"Yahoo Finance","summary":"Demand for workers in the U.S. remained historically elevated in November, with job openings holding","content":"<html><head></head><body><p>Demand for workers in the U.S. remained historically elevated in November, with job openings holding near a record high amid the ongoing pandemic.</p><p>Vacancies totaled 10.562 million in November, according to the Labor Department&#39;s Job Openings and Labor Turnover Summary (JOLTS) released Tuesday.This comes is slightly lower than the 11.033 million in October, based on the government&#39;s first estimate for the month. Consensus economists were looking for job openings to rise to 11.079 million in November, according to Bloomberg data.</p><p>Tuesday&#39;s report extends a streak of elevated readings on job openings. Vacancies rose throughout early 2021 and reached a record high of 11.098 million in July, and have retreated only modestly since then.</p><p>And while the JOLTS report for November does not yet capture any meaningful impact from the Omicron variant discovered around Thanksgiving, some economists suggested labor shortages may be exacerbated at least in the near-term due to the latest surge.</p><p>&#34;Looking ahead, the Omicron variant wave will likely lead to some short-term weakness in the labor market,&#34; Sam Bullard, senior economist for Wells Fargo, wrote in a note published earlier this week. &#34;However, we believe this will be temporary and that the pace of hiring should pick back up by the spring.&#34;</p><p>The JOLTS data also adds to a slew of other reports pointing to the persistent tightness in the U.S. labor market. The last monthly jobs report from the Labor Department showed a disappointing 210,000 non-farm payrolls came back in the penultimate month of last year.The labor force participation rate remained depressed compared to pre-pandemic levels, and the civilian labor force was still down by about 2.4 million participants versus levels from February 2020. And according to the latest NFIB Small Business Optimism report,nearly half of surveyed owners said they had job openings that could not be filled in November. The December jobs report is slated to be released on Friday.</p><p>But while labor shortages have continued to strain employers seeking to fill positions, leverage among workers has increased. Average hourly earnings last rose at a 4.8% year-over-year clip in November, though this rise was dwarfed by the 6.8% jump in U.S. consumer prices during the same month,according to data from the Bureau of Labor Statistics.</p><p>And the Conference Board&#39;s consumer confidence survey last month showed a labor differential — or percentage of those saying jobs were &#34;plentiful&#34; less those saying jobs were &#34;hard to get&#34; — that was still elevated on a historical basis, suggesting workers were still finding it relatively easy to find jobs.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Job Openings Reach 10.6 Million in November as Tight Labor Market Persists</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJob Openings Reach 10.6 Million in November as Tight Labor Market Persists\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 23:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/jolts-job-openings-labor-department-november-2021-150154251.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Demand for workers in the U.S. remained historically elevated in November, with job openings holding near a record high amid the ongoing pandemic.Vacancies totaled 10.562 million in November, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/jolts-job-openings-labor-department-november-2021-150154251.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/jolts-job-openings-labor-department-november-2021-150154251.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108070113","content_text":"Demand for workers in the U.S. remained historically elevated in November, with job openings holding near a record high amid the ongoing pandemic.Vacancies totaled 10.562 million in November, according to the Labor Department's Job Openings and Labor Turnover Summary (JOLTS) released Tuesday.This comes is slightly lower than the 11.033 million in October, based on the government's first estimate for the month. Consensus economists were looking for job openings to rise to 11.079 million in November, according to Bloomberg data.Tuesday's report extends a streak of elevated readings on job openings. Vacancies rose throughout early 2021 and reached a record high of 11.098 million in July, and have retreated only modestly since then.And while the JOLTS report for November does not yet capture any meaningful impact from the Omicron variant discovered around Thanksgiving, some economists suggested labor shortages may be exacerbated at least in the near-term due to the latest surge.\"Looking ahead, the Omicron variant wave will likely lead to some short-term weakness in the labor market,\" Sam Bullard, senior economist for Wells Fargo, wrote in a note published earlier this week. \"However, we believe this will be temporary and that the pace of hiring should pick back up by the spring.\"The JOLTS data also adds to a slew of other reports pointing to the persistent tightness in the U.S. labor market. The last monthly jobs report from the Labor Department showed a disappointing 210,000 non-farm payrolls came back in the penultimate month of last year.The labor force participation rate remained depressed compared to pre-pandemic levels, and the civilian labor force was still down by about 2.4 million participants versus levels from February 2020. And according to the latest NFIB Small Business Optimism report,nearly half of surveyed owners said they had job openings that could not be filled in November. The December jobs report is slated to be released on Friday.But while labor shortages have continued to strain employers seeking to fill positions, leverage among workers has increased. Average hourly earnings last rose at a 4.8% year-over-year clip in November, though this rise was dwarfed by the 6.8% jump in U.S. consumer prices during the same month,according to data from the Bureau of Labor Statistics.And the Conference Board's consumer confidence survey last month showed a labor differential — or percentage of those saying jobs were \"plentiful\" less those saying jobs were \"hard to get\" — that was still elevated on a historical basis, suggesting workers were still finding it relatively easy to find jobs.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001611904,"gmtCreate":1641244765911,"gmtModify":1676533586244,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Like]&nbsp;[Like]&nbsp;[Like]&nbsp;","listText":"[Like]&nbsp;[Like]&nbsp;[Like]&nbsp;","text":"[Like] [Like] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001611904","repostId":"1183292036","repostType":4,"repost":{"id":"1183292036","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641221573,"share":"https://ttm.financial/m/news/1183292036?lang=en_US&edition=fundamental","pubTime":"2022-01-03 22:52","market":"us","language":"en","title":"Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183292036","media":"Tiger Newspress","summary":"Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding near","content":"<html><head></head><body><p>Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%.<img src=\"https://static.tigerbbs.com/cc0c7b24178536a86f84c6ed3434a3ff\" tg-width=\"286\" tg-height=\"472\" referrerpolicy=\"no-referrer\"/>Last week, Israel approved a fourth dose Pfizer(NYSE:PFE) and BioNTech&#39;s(NASDAQ:BNTX) vaccine, a second booster, for people who are immune-compromised and the elderly living in care homes.</p><p>&#34;We now have a new layer of defense,&#34; Prime Minister Naftali Bennett said in a news conference, adding that Israel&#39;s top government medical official had signed off on the latest move.</p><p>&#34;Israel will once again be pioneering the global vaccination effort,&#34; Bennett said.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-03 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%.<img src=\"https://static.tigerbbs.com/cc0c7b24178536a86f84c6ed3434a3ff\" tg-width=\"286\" tg-height=\"472\" referrerpolicy=\"no-referrer\"/>Last week, Israel approved a fourth dose Pfizer(NYSE:PFE) and BioNTech&#39;s(NASDAQ:BNTX) vaccine, a second booster, for people who are immune-compromised and the elderly living in care homes.</p><p>&#34;We now have a new layer of defense,&#34; Prime Minister Naftali Bennett said in a news conference, adding that Israel&#39;s top government medical official had signed off on the latest move.</p><p>&#34;Israel will once again be pioneering the global vaccination effort,&#34; Bennett said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183292036","content_text":"Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%.Last week, Israel approved a fourth dose Pfizer(NYSE:PFE) and BioNTech's(NASDAQ:BNTX) vaccine, a second booster, for people who are immune-compromised and the elderly living in care homes.\"We now have a new layer of defense,\" Prime Minister Naftali Bennett said in a news conference, adding that Israel's top government medical official had signed off on the latest move.\"Israel will once again be pioneering the global vaccination effort,\" Bennett said.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":3208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836741524,"gmtCreate":1629529589168,"gmtModify":1676530066683,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"Good...&nbsp;","listText":"Good...&nbsp;","text":"Good...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836741524","repostId":"2161746147","repostType":4,"isVote":1,"tweetType":1,"viewCount":2780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9001611904,"gmtCreate":1641244765911,"gmtModify":1676533586244,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Like]&nbsp;[Like]&nbsp;[Like]&nbsp;","listText":"[Like]&nbsp;[Like]&nbsp;[Like]&nbsp;","text":"[Like] [Like] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001611904","repostId":"1183292036","repostType":4,"repost":{"id":"1183292036","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641221573,"share":"https://ttm.financial/m/news/1183292036?lang=en_US&edition=fundamental","pubTime":"2022-01-03 22:52","market":"us","language":"en","title":"Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183292036","media":"Tiger Newspress","summary":"Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding near","content":"<html><head></head><body><p>Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%.<img src=\"https://static.tigerbbs.com/cc0c7b24178536a86f84c6ed3434a3ff\" tg-width=\"286\" tg-height=\"472\" referrerpolicy=\"no-referrer\"/>Last week, Israel approved a fourth dose Pfizer(NYSE:PFE) and BioNTech&#39;s(NASDAQ:BNTX) vaccine, a second booster, for people who are immune-compromised and the elderly living in care homes.</p><p>&#34;We now have a new layer of defense,&#34; Prime Minister Naftali Bennett said in a news conference, adding that Israel&#39;s top government medical official had signed off on the latest move.</p><p>&#34;Israel will once again be pioneering the global vaccination effort,&#34; Bennett said.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-03 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%.<img src=\"https://static.tigerbbs.com/cc0c7b24178536a86f84c6ed3434a3ff\" tg-width=\"286\" tg-height=\"472\" referrerpolicy=\"no-referrer\"/>Last week, Israel approved a fourth dose Pfizer(NYSE:PFE) and BioNTech&#39;s(NASDAQ:BNTX) vaccine, a second booster, for people who are immune-compromised and the elderly living in care homes.</p><p>&#34;We now have a new layer of defense,&#34; Prime Minister Naftali Bennett said in a news conference, adding that Israel&#39;s top government medical official had signed off on the latest move.</p><p>&#34;Israel will once again be pioneering the global vaccination effort,&#34; Bennett said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183292036","content_text":"Vaccine stocks tumbled in morning trading, with Moderna sliding over 8% and BioNTech SE sliding nearly 7%.Last week, Israel approved a fourth dose Pfizer(NYSE:PFE) and BioNTech's(NASDAQ:BNTX) vaccine, a second booster, for people who are immune-compromised and the elderly living in care homes.\"We now have a new layer of defense,\" Prime Minister Naftali Bennett said in a news conference, adding that Israel's top government medical official had signed off on the latest move.\"Israel will once again be pioneering the global vaccination effort,\" Bennett said.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":3208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836741524,"gmtCreate":1629529589168,"gmtModify":1676530066683,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"Good...&nbsp;","listText":"Good...&nbsp;","text":"Good...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836741524","repostId":"2161746147","repostType":4,"isVote":1,"tweetType":1,"viewCount":2780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9035140506,"gmtCreate":1647558026338,"gmtModify":1676534242901,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Call]&nbsp;","listText":"[Call]&nbsp;","text":"[Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035140506","repostId":"1165019745","repostType":4,"repost":{"id":"1165019745","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647530294,"share":"https://ttm.financial/m/news/1165019745?lang=en_US&edition=fundamental","pubTime":"2022-03-17 23:18","market":"us","language":"en","title":"Pfizer Shares Rose More Than 2% in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1165019745","media":"Tiger Newspress","summary":"Pfizer shares rose more than 2% in morning trading.Thirty five generic drugmakers around the world w","content":"<html><head></head><body><p>Pfizer shares rose more than 2% in morning trading.<img src=\"https://static.tigerbbs.com/4a03e4c180b16dbc8dee58435f81f61a\" tg-width=\"713\" tg-height=\"629\" referrerpolicy=\"no-referrer\"/>Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc&#39;s highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday.</p><p>Pfizer struck a deal last year with the group to allow generic drugmakers to make the pills for 95 low- and middle-income countries. They have been working since then to select the drugmakers they will license.</p><p>Paxlovid is expected to be an important tool in the fight against COVID-19 after it reduced hospitalizations in high-risk patients by around 90% in a clinical trial. The results were significantly better than those for Merck &amp; Co&#39;s rival antiviral pill molnupiravir in its clinical trial.</p><p>Pfizer won’t receive royalties from sales covered by the pact as long as Covid remains classified as an international public-health emergency by the World Health Organization, according to the patent pool.</p><p>After the pandemic, middle-income nations will be subject to a 5% royalty for sales to the public sector and 10% for sales to the private sector. There will be no royalty payment for low-income countries.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shares Rose More Than 2% in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shares Rose More Than 2% in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 23:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Pfizer shares rose more than 2% in morning trading.<img src=\"https://static.tigerbbs.com/4a03e4c180b16dbc8dee58435f81f61a\" tg-width=\"713\" tg-height=\"629\" referrerpolicy=\"no-referrer\"/>Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc&#39;s highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday.</p><p>Pfizer struck a deal last year with the group to allow generic drugmakers to make the pills for 95 low- and middle-income countries. They have been working since then to select the drugmakers they will license.</p><p>Paxlovid is expected to be an important tool in the fight against COVID-19 after it reduced hospitalizations in high-risk patients by around 90% in a clinical trial. The results were significantly better than those for Merck &amp; Co&#39;s rival antiviral pill molnupiravir in its clinical trial.</p><p>Pfizer won’t receive royalties from sales covered by the pact as long as Covid remains classified as an international public-health emergency by the World Health Organization, according to the patent pool.</p><p>After the pandemic, middle-income nations will be subject to a 5% royalty for sales to the public sector and 10% for sales to the private sector. There will be no royalty payment for low-income countries.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165019745","content_text":"Pfizer shares rose more than 2% in morning trading.Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc's highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the U.N.-backed Medicines Patent Pool (MPP) said on Thursday.Pfizer struck a deal last year with the group to allow generic drugmakers to make the pills for 95 low- and middle-income countries. They have been working since then to select the drugmakers they will license.Paxlovid is expected to be an important tool in the fight against COVID-19 after it reduced hospitalizations in high-risk patients by around 90% in a clinical trial. The results were significantly better than those for Merck & Co's rival antiviral pill molnupiravir in its clinical trial.Pfizer won’t receive royalties from sales covered by the pact as long as Covid remains classified as an international public-health emergency by the World Health Organization, according to the patent pool.After the pandemic, middle-income nations will be subject to a 5% royalty for sales to the public sector and 10% for sales to the private sector. There will be no royalty payment for low-income countries.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006309930,"gmtCreate":1641601562751,"gmtModify":1676533633018,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Surprised]&nbsp;[Surprised]&nbsp;[Surprised]&nbsp;","listText":"[Surprised]&nbsp;[Surprised]&nbsp;[Surprised]&nbsp;","text":"[Surprised] [Surprised] [Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006309930","repostId":"1120541362","repostType":4,"repost":{"id":"1120541362","kind":"news","pubTimestamp":1641598507,"share":"https://ttm.financial/m/news/1120541362?lang=en_US&edition=fundamental","pubTime":"2022-01-08 07:35","market":"us","language":"en","title":"GameStop Price Alert: Are NFTs and Cryptos Enough to End Bear Market?","url":"https://stock-news.laohu8.com/highlight/detail?id=1120541362","media":"TheStreet","summary":"GameStop stock has been under a ton of pressure lately. However, the market is selling the news on i","content":"<html><head></head><body><p>GameStop stock has been under a ton of pressure lately. However, the market is selling the news on its NFTs and crypto plan.</p><p>Forget the employment report. GameStop wanted the spotlight on Friday, which helped vault it higher by more than 20% at the open.</p><p>Driving the gains is the company’s new plan to leverage NFTs and cryptocurrencies. From an earlier piece on <i>TheStreet:</i></p><blockquote>&#34;It looks like GameStop&#39;s launch in crypto is going to start with trying to be a leading marketplace for gaming NFT&#39;s,&#34; Hedgeye Risk Management analyst Jeremy Mclean said in a note this week. &#34;GameStop is one of the first real Retail brand names in this NFT space. We think there is a real commercial opportunity to being there.&#34;</blockquote><p>While the stock soared on the news in pre-market trading, it was up even more in the after-hours on Thursday.</p><p>However, the stock has since faded from the open and is now up “just” 7.3%.</p><p>That’s not bad given the mixed picture in the overall market following the labor report, but it’s a blow to those who were long and had large gains at the open.</p><p>Worse, the fade came from an important area on the chart.</p><p><b>Trading GameStop Stock</b></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/024bc53e87a739a2f541f98b362554fb\" tg-width=\"1139\" tg-height=\"866\" referrerpolicy=\"no-referrer\"/><span>Daily chart of GameStop stock.</span></p><p>On Dec. 3, GameStop stock pulled back to $159.05 and bounced, but plunged back below that mark a few days later when the company reported disappointing earnings.</p><p>That level quickly turned into resistance, an observation that remained true on Friday morning.</p><p>I flagged the $159 level ahead of earnings, arguing that a break of it could put the $116 to $118 area in play.</p><p>The stock ended up bottoming about $3 above that range, at $121-and-change. So what do we do from here?</p><p>Following that painful but obvious rejection from this morning, GameStop isn’t done disappointing the bulls. Shares knifed right through the 10-day and 21-day moving averages as well.</p><p>It simply <i>has</i> to find its footing before bulls can trust it on the long side.</p><p>So far, the fourth-quarter low at $129.50 has been a decent area of stability. Even amid the one break lower that sent GameStop stock to the $121.14 low, the stock was still able to close over the fourth-quarter low by the end of the session.</p><p>On the plus side, it did fill today’s gap.</p><p>Over Thursday high at $137.70 and<i>aggressive</i>bulls can be long GameStop, targeting the 10-day and 21-day moving averages as the first target, then $159 as the second.</p><p>Above $160.50 and GameStop could make a run to its 50-day moving average.</p><p>Otherwise, below $137.70 and the fourth-quarter low is in play, while the 2022 low remains vulnerable.</p><p>Personally, I wouldn&#39;t consider GameStop a safe trade on the long side. Not after today&#39;s heavy fade.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop Price Alert: Are NFTs and Cryptos Enough to End Bear Market?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop Price Alert: Are NFTs and Cryptos Enough to End Bear Market?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 07:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/trading-gamestop-gme-stock-nft-crypto-plans><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GameStop stock has been under a ton of pressure lately. However, the market is selling the news on its NFTs and crypto plan.Forget the employment report. GameStop wanted the spotlight on Friday, which...</p>\n\n<a href=\"https://www.thestreet.com/investing/trading-gamestop-gme-stock-nft-crypto-plans\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://www.thestreet.com/investing/trading-gamestop-gme-stock-nft-crypto-plans","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120541362","content_text":"GameStop stock has been under a ton of pressure lately. However, the market is selling the news on its NFTs and crypto plan.Forget the employment report. GameStop wanted the spotlight on Friday, which helped vault it higher by more than 20% at the open.Driving the gains is the company’s new plan to leverage NFTs and cryptocurrencies. From an earlier piece on TheStreet:\"It looks like GameStop's launch in crypto is going to start with trying to be a leading marketplace for gaming NFT's,\" Hedgeye Risk Management analyst Jeremy Mclean said in a note this week. \"GameStop is one of the first real Retail brand names in this NFT space. We think there is a real commercial opportunity to being there.\"While the stock soared on the news in pre-market trading, it was up even more in the after-hours on Thursday.However, the stock has since faded from the open and is now up “just” 7.3%.That’s not bad given the mixed picture in the overall market following the labor report, but it’s a blow to those who were long and had large gains at the open.Worse, the fade came from an important area on the chart.Trading GameStop StockDaily chart of GameStop stock.On Dec. 3, GameStop stock pulled back to $159.05 and bounced, but plunged back below that mark a few days later when the company reported disappointing earnings.That level quickly turned into resistance, an observation that remained true on Friday morning.I flagged the $159 level ahead of earnings, arguing that a break of it could put the $116 to $118 area in play.The stock ended up bottoming about $3 above that range, at $121-and-change. So what do we do from here?Following that painful but obvious rejection from this morning, GameStop isn’t done disappointing the bulls. Shares knifed right through the 10-day and 21-day moving averages as well.It simply has to find its footing before bulls can trust it on the long side.So far, the fourth-quarter low at $129.50 has been a decent area of stability. Even amid the one break lower that sent GameStop stock to the $121.14 low, the stock was still able to close over the fourth-quarter low by the end of the session.On the plus side, it did fill today’s gap.Over Thursday high at $137.70 andaggressivebulls can be long GameStop, targeting the 10-day and 21-day moving averages as the first target, then $159 as the second.Above $160.50 and GameStop could make a run to its 50-day moving average.Otherwise, below $137.70 and the fourth-quarter low is in play, while the 2022 low remains vulnerable.Personally, I wouldn't consider GameStop a safe trade on the long side. Not after today's heavy fade.","news_type":1,"symbols_score_info":{"GME":0.9}},"isVote":1,"tweetType":1,"viewCount":2662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001785573,"gmtCreate":1641332984240,"gmtModify":1676533597638,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;","listText":"[Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;","text":"[Miser] [Miser] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001785573","repostId":"1108070113","repostType":4,"repost":{"id":"1108070113","kind":"news","pubTimestamp":1641308842,"share":"https://ttm.financial/m/news/1108070113?lang=en_US&edition=fundamental","pubTime":"2022-01-04 23:07","market":"us","language":"en","title":"Job Openings Reach 10.6 Million in November as Tight Labor Market Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=1108070113","media":"Yahoo Finance","summary":"Demand for workers in the U.S. remained historically elevated in November, with job openings holding","content":"<html><head></head><body><p>Demand for workers in the U.S. remained historically elevated in November, with job openings holding near a record high amid the ongoing pandemic.</p><p>Vacancies totaled 10.562 million in November, according to the Labor Department&#39;s Job Openings and Labor Turnover Summary (JOLTS) released Tuesday.This comes is slightly lower than the 11.033 million in October, based on the government&#39;s first estimate for the month. Consensus economists were looking for job openings to rise to 11.079 million in November, according to Bloomberg data.</p><p>Tuesday&#39;s report extends a streak of elevated readings on job openings. Vacancies rose throughout early 2021 and reached a record high of 11.098 million in July, and have retreated only modestly since then.</p><p>And while the JOLTS report for November does not yet capture any meaningful impact from the Omicron variant discovered around Thanksgiving, some economists suggested labor shortages may be exacerbated at least in the near-term due to the latest surge.</p><p>&#34;Looking ahead, the Omicron variant wave will likely lead to some short-term weakness in the labor market,&#34; Sam Bullard, senior economist for Wells Fargo, wrote in a note published earlier this week. &#34;However, we believe this will be temporary and that the pace of hiring should pick back up by the spring.&#34;</p><p>The JOLTS data also adds to a slew of other reports pointing to the persistent tightness in the U.S. labor market. The last monthly jobs report from the Labor Department showed a disappointing 210,000 non-farm payrolls came back in the penultimate month of last year.The labor force participation rate remained depressed compared to pre-pandemic levels, and the civilian labor force was still down by about 2.4 million participants versus levels from February 2020. And according to the latest NFIB Small Business Optimism report,nearly half of surveyed owners said they had job openings that could not be filled in November. The December jobs report is slated to be released on Friday.</p><p>But while labor shortages have continued to strain employers seeking to fill positions, leverage among workers has increased. Average hourly earnings last rose at a 4.8% year-over-year clip in November, though this rise was dwarfed by the 6.8% jump in U.S. consumer prices during the same month,according to data from the Bureau of Labor Statistics.</p><p>And the Conference Board&#39;s consumer confidence survey last month showed a labor differential — or percentage of those saying jobs were &#34;plentiful&#34; less those saying jobs were &#34;hard to get&#34; — that was still elevated on a historical basis, suggesting workers were still finding it relatively easy to find jobs.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Job Openings Reach 10.6 Million in November as Tight Labor Market Persists</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJob Openings Reach 10.6 Million in November as Tight Labor Market Persists\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 23:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/jolts-job-openings-labor-department-november-2021-150154251.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Demand for workers in the U.S. remained historically elevated in November, with job openings holding near a record high amid the ongoing pandemic.Vacancies totaled 10.562 million in November, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/jolts-job-openings-labor-department-november-2021-150154251.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/jolts-job-openings-labor-department-november-2021-150154251.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108070113","content_text":"Demand for workers in the U.S. remained historically elevated in November, with job openings holding near a record high amid the ongoing pandemic.Vacancies totaled 10.562 million in November, according to the Labor Department's Job Openings and Labor Turnover Summary (JOLTS) released Tuesday.This comes is slightly lower than the 11.033 million in October, based on the government's first estimate for the month. Consensus economists were looking for job openings to rise to 11.079 million in November, according to Bloomberg data.Tuesday's report extends a streak of elevated readings on job openings. Vacancies rose throughout early 2021 and reached a record high of 11.098 million in July, and have retreated only modestly since then.And while the JOLTS report for November does not yet capture any meaningful impact from the Omicron variant discovered around Thanksgiving, some economists suggested labor shortages may be exacerbated at least in the near-term due to the latest surge.\"Looking ahead, the Omicron variant wave will likely lead to some short-term weakness in the labor market,\" Sam Bullard, senior economist for Wells Fargo, wrote in a note published earlier this week. \"However, we believe this will be temporary and that the pace of hiring should pick back up by the spring.\"The JOLTS data also adds to a slew of other reports pointing to the persistent tightness in the U.S. labor market. The last monthly jobs report from the Labor Department showed a disappointing 210,000 non-farm payrolls came back in the penultimate month of last year.The labor force participation rate remained depressed compared to pre-pandemic levels, and the civilian labor force was still down by about 2.4 million participants versus levels from February 2020. And according to the latest NFIB Small Business Optimism report,nearly half of surveyed owners said they had job openings that could not be filled in November. The December jobs report is slated to be released on Friday.But while labor shortages have continued to strain employers seeking to fill positions, leverage among workers has increased. Average hourly earnings last rose at a 4.8% year-over-year clip in November, though this rise was dwarfed by the 6.8% jump in U.S. consumer prices during the same month,according to data from the Bureau of Labor Statistics.And the Conference Board's consumer confidence survey last month showed a labor differential — or percentage of those saying jobs were \"plentiful\" less those saying jobs were \"hard to get\" — that was still elevated on a historical basis, suggesting workers were still finding it relatively easy to find jobs.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9014475560,"gmtCreate":1649716591889,"gmtModify":1676534554292,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;","listText":"[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;","text":"[Call] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9014475560","repostId":"9014585114","repostType":1,"repost":{"id":9014585114,"gmtCreate":1649684354587,"gmtModify":1676534550460,"author":{"id":"3581582691031963","authorId":"3581582691031963","name":"mantaru","avatar":"https://static.tigerbbs.com/d383ec25018126b5add320ac3acf90aa","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581582691031963","idStr":"3581582691031963"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/V\">$Visa(V)$</a>the great red","listText":"<a href=\"https://ttm.financial/S/V\">$Visa(V)$</a>the great red","text":"$Visa(V)$the great red","images":[{"img":"https://community-static.tradeup.com/news/8cd9fbd56551df80544477624d2f037c","width":"1080","height":"3182"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9014585114","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9031814765,"gmtCreate":1646519895270,"gmtModify":1676534135565,"author":{"id":"4090666679009510","authorId":"4090666679009510","name":"Jacksim","avatar":"https://static.tigerbbs.com/cad02c18681a5073da96066b242bdaca","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090666679009510","idStr":"4090666679009510"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031814765","repostId":"1123705020","repostType":4,"repost":{"id":"1123705020","kind":"news","pubTimestamp":1646439679,"share":"https://ttm.financial/m/news/1123705020?lang=en_US&edition=fundamental","pubTime":"2022-03-05 08:21","market":"us","language":"en","title":"US IPO Week Ahead: Market Slowdown Continues with No IPOs Scheduled","url":"https://stock-news.laohu8.com/highlight/detail?id=1123705020","media":"Renaissance Capital","summary":"No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar","content":"<html><head></head><body><p>No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar during the week.</p><p>The typical February lull was quieter than expected, with few large filings and no launches after Presidents’ Day in light of the repercussions of war in Europe. There are a number of large issuers waiting in the pipeline once the IPO market becomes more amenable, led by Bausch Health spin-off <b>Bausch + Lomb</b>(BLCO) and Greek yogurt brand <b>Chobani</b>(CHO), which aims to be the latest public benefit corp to go public.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Market Slowdown Continues with No IPOs Scheduled</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Market Slowdown Continues with No IPOs Scheduled\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-05 08:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/91318/US-IPO-Week-Ahead-Market-slowdown-continues-with-no-IPOs-scheduled><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar during the week.The typical February lull was quieter than expected, with few large filings and no ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/91318/US-IPO-Week-Ahead-Market-slowdown-continues-with-no-IPOs-scheduled\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/91318/US-IPO-Week-Ahead-Market-slowdown-continues-with-no-IPOs-scheduled","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123705020","content_text":"No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar during the week.The typical February lull was quieter than expected, with few large filings and no launches after Presidents’ Day in light of the repercussions of war in Europe. There are a number of large issuers waiting in the pipeline once the IPO market becomes more amenable, led by Bausch Health spin-off Bausch + Lomb(BLCO) and Greek yogurt brand Chobani(CHO), which aims to be the latest public benefit corp to go public.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1978,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}